Application of reagent for detecting expression levels of two biomarkers in sample in preparation of kit for detecting preeclampsia

A biomarker and preeclampsia technology, applied in the field of biomedicine, can solve problems such as diagnosis and clinical management decision-making difficulties, diagnosis dependence, etc., to achieve the effect of ensuring maternal and child safety, controlling disease, and prolonging gestational age

Pending Publication Date: 2021-10-29
天津云检医疗器械有限公司 +1
View PDF20 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The causes and pathogenesis of preeclampsia remain uncertain, and diagnosis relies on laboratory and clinical signs and symptoms that develop later in the nonspecific course, making diagnostic and clinical management decisions difficult

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of reagent for detecting expression levels of two biomarkers in sample in preparation of kit for detecting preeclampsia
  • Application of reagent for detecting expression levels of two biomarkers in sample in preparation of kit for detecting preeclampsia
  • Application of reagent for detecting expression levels of two biomarkers in sample in preparation of kit for detecting preeclampsia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0038] The present invention will be further described in detail below in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described here are only used to explain the present invention, but not to limit the present invention. In addition, it should be noted that, for the convenience of description, only some of the test results related to the present invention are shown in the drawings but not all of them.

[0039] The present invention provides a method for obtaining the expression of the preeclampsia (preeclampsia, PE) marker level in the human body of the subject. The indication of the level of preeclampsia markers refers to the characteristic characteristics such as the amount and presence or absence of the preeclampsia marker content of one or more subjects, for example, the concentration of the preeclampsia markers in a group of subjects' biological samples. The term "biological sample" includes various ty...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

According to the invention, the ratio of biomarkers leptin to ceramide related to preeclampsia is found for the first time, and early diagnosis of preeclampsia is realized by detecting the level change of the ratio of leptin to ceramide of a subject. The method can be used for evaluating the preeclampsia disease risk during pregnancy, has high accuracy and specificity, and provides an effective method for early prediction and precise prevention of preeclampsia. In the early stage of morbidity, timely and accurate auxiliary diagnosis is carried out on pregnant women with preeclampsia risks, clinical close monitoring on patients is helped, effective intervention is timely carried out to control the illness state and prolong the gestational week, and the method has important significance in reducing the preeclampsia morbidity and mortality rate and guaranteeing the safety of mothers and infants.

Description

technical field [0001] The invention belongs to the field of biomedicine and relates to the application of a reagent for detecting the expression levels of two biomarkers in a sample in the preparation of a kit for detecting preeclampsia. Background technique [0002] Preeclampsia, also known as preeclampsia (PE), is a serious multisystem complication of pregnancy that has adverse effects on both mother and baby. The incidence of the disease accounts for about 5-8% of all pregnancies in China and globally, the disease is responsible for 18% of all maternal deaths worldwide, and is also the leading cause of fetal and neonatal deaths. In medicine, patients with preeclampsia or the risk of preeclampsia are called preeclampsia patients. Clinical presentation is variable, but hypertension and proteinuria are often seen. The characteristics are as follows: new-onset hypertension and proteinuria after 20 weeks; with or without thrombocytopenia, renal function damage, liver functi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/74G01N33/58G01N30/02G01N30/06G01N30/72G01N30/86
CPCG01N33/74G01N33/581G01N30/02G01N30/06G01N30/72G01N30/8675G01N2333/575G01N2800/368
Inventor 陈利民李振
Owner 天津云检医疗器械有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap